Ramin Najafi Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ramin Najafi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ramin Najafi. Ramin Najafi is Chief Executive Officer in NovaBay Pharmaceuticals, Inc. ($NBY).
Latest Insider Trading Transactions of Ramin Najafi
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 21 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.44 | 6,000 | 2,640 | 12,000 | 6 K to 12 K (+100.00 %) |
Aug 21 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.50 | 6,000 | 3,000 | 6,000 | 0 to 6 K |
Mar 25 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 0.00 | 46,033 | 0 | 3,437,699 | 3.4 M to 3.4 M (+1.36 %) |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | P | 0.65 | 124,999 | 81,249 | 291,665 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | P | 0.60 | 166,666 | 100,000 | 291,665 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.60 | 166,666 | 100,000 | 3,391,666 | 3.2 M to 3.4 M (+5.17 %) |
Dec 15 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.65 | 50,000 | 32,500 | 0 | -50,000 to 0 (-100.00 %) |
Dec 11 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.60 | 20,000 | 12,000 | 3,175,000 | 3.2 M to 3.2 M (+0.63 %) |
Dec 08 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.65 | 25,000 | 16,250 | 3,155,000 | 3.1 M to 3.2 M (+0.80 %) |
Dec 04 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.71 | 18,000 | 12,780 | 3,130,000 | 3.1 M to 3.1 M (+0.58 %) |
Sep 30 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 0.75 | 90,000 | 67,500 | 1,015,032 | |
Jun 04 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Gift | G | 0.00 | 5,500 | 0 | 3,112,000 | 3.1 M to 3.1 M (-0.18 %) |
Apr 17 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.00 | 10,180 | 10,180 | 925,032 | |
Oct 29 2013 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Payment of Exercise | F | 1.75 | 4,557 | 7,975 | 100,195 | 104.8 K to 100.2 K (-4.35 %) |
Oct 02 2013 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.71 | 150,000 | 256,500 | 914,852 | |
Jan 14 2013 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.13 | 85,000 | 96,050 | 764,852 | |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | P | 1.50 | 15,000 | 22,500 | 15,000 | |
Dec 10 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.24 | 20,000 | 24,800 | 100,195 | 80.2 K to 100.2 K (+24.94 %) |
Dec 04 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Payment of Exercise | F | 1.31 | 4,557 | 5,970 | 80,195 | 84.8 K to 80.2 K (-5.38 %) |
Oct 12 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.29 | 65,000 | 83,850 | 679,852 | |
May 29 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.99 | 3,500 | 3,465 | 28,752 | 25.3 K to 28.8 K (+13.86 %) |
May 30 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.96 | 2,000 | 1,920 | 34,752 | 32.8 K to 34.8 K (+6.11 %) |
May 30 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.96 | 4,000 | 3,836 | 32,752 | 28.8 K to 32.8 K (+13.91 %) |
Feb 23 2012 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.44 | 96,652 | 139,179 | 614,852 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.09 | 70,000 | 76,300 | 518,200 | |
Nov 01 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 1.09 | 50,000 | 54,500 | 202,673 | 152.7 K to 202.7 K (+32.75 %) |
Oct 03 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 0.90 | 152,673 | 137,406 | 177,925 | 25.3 K to 177.9 K (+604.60 %) |
Aug 16 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.85 | 10,000 | 8,500 | 25,252 | 15.3 K to 25.3 K (+65.57 %) |
May 31 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.59 | 500 | 797 | 15,252 | 14.8 K to 15.3 K (+3.39 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.60 | 500 | 798 | 14,752 | 14.3 K to 14.8 K (+3.51 %) |
May 27 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.60 | 500 | 799 | 14,252 | 13.8 K to 14.3 K (+3.64 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.73 | 552 | 954 | 13,752 | 13.2 K to 13.8 K (+4.18 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.74 | 500 | 869 | 13,200 | 12.7 K to 13.2 K (+3.94 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.72 | 500 | 860 | 12,700 | 12.2 K to 12.7 K (+4.10 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.67 | 200 | 334 | 12,200 | 12 K to 12.2 K (+1.67 %) |
May 26 2011 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.69 | 800 | 1,354 | 12,000 | 11.2 K to 12 K (+7.14 %) |
Aug 28 2009 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.92 | 1,000 | 1,920 | 11,200 | 10.2 K to 11.2 K (+9.80 %) |
Dec 11 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.14 | 500 | 570 | 10,200 | 9.7 K to 10.2 K (+5.15 %) |
Sep 16 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 1.81 | 100 | 181 | 9,700 | 9.6 K to 9.7 K (+1.04 %) |
Sep 16 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 1.81 | 500 | 905 | 9,600 | 9.1 K to 9.6 K (+5.49 %) |
Sep 16 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 1.82 | 400 | 728 | 9,100 | 8.7 K to 9.1 K (+4.60 %) |
Aug 20 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.97 | 600 | 1,182 | 6,200 | 5.6 K to 6.2 K (+10.71 %) |
Aug 20 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.10 | 1,000 | 2,100 | 5,600 | 4.6 K to 5.6 K (+21.74 %) |
Aug 20 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 1.93 | 1,000 | 1,930 | 4,600 | 3.6 K to 4.6 K (+27.78 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.75 | 2,000 | 5,500 | 3,600 | 1.6 K to 3.6 K (+125.00 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.50 | 600 | 1,500 | 1,600 | 1,000 to 1.6 K (+60.00 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.77 | 1,000 | 2,770 | 1,000 | 0 to 1,000 |
Dec 18 2007 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 3.56 | 125,000 | 445,000 | 125,000 |
Page: 1